Stay updated on Pembrolizumab for Advanced Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded Revision: v3.5.0. Removed Revision: v3.4.3.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.1%

- Check74 days agoChange DetectedGlossary toggle controls were added (Show glossary / Hide glossary) and the footer now includes a revision tag (Revision: v3.4.0) along with updated QC criteria text and a No FEAR Act Data notice.SummaryDifference0.3%

- Check82 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be a metadata update rather than a modification of study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Advanced Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.